Sinopharm's subsidiary CNBG was one of the earliest coronavirus vaccine developers to push for human trials and the world’s first to enter the final stage of trials. Photo: AP
Sinopharm's subsidiary CNBG was one of the earliest coronavirus vaccine developers to push for human trials and the world’s first to enter the final stage of trials. Photo: AP

Coronavirus: Sinopharm applies for regulatory approval from China to launch vaccine, state media reports

  • Chinese pharmaceutical giant files for regulatory approval, according to Xinhua Finance
  • China National Biotec Group executive says data review is not complete but Sinopharm chairman says vaccines are protective and safe

Sinopharm's subsidiary CNBG was one of the earliest coronavirus vaccine developers to push for human trials and the world’s first to enter the final stage of trials. Photo: AP
Sinopharm's subsidiary CNBG was one of the earliest coronavirus vaccine developers to push for human trials and the world’s first to enter the final stage of trials. Photo: AP
READ FULL ARTICLE